Beacon Pointe Advisors
GOSS icon

Beacon Pointe Advisors’s Gossamer Bio GOSS Stock Holding History

Beacon Pointe Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.9K Buy
600
+250
+71% +$5.58K ﹤0.01% 1913
2026
Q1 		$9.2K Buy
350
+212
+154% +$26.7K ﹤0.01% 1827
2025
Q4 		$34.1K Buy
+138
New +$31.5K ﹤0.01% 1490

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Beacon Pointe Advisors's GOSS Position: Q2 2026 in Review

Beacon Pointe Advisors increased its Gossamer Bio (GOSS) stake by 71% in Q2 2026, buying an estimated $5.58K and bringing the position to 600 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Beacon Pointe Advisors first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $34.1K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Beacon Pointe Advisors held 600 shares of Gossamer Bio worth $7.9K as of Q2 2026.
  • Beacon Pointe Advisors bought 250 Gossamer Bio shares in Q2 2026, an estimated $5.58K.
  • Gossamer Bio made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1913 holding.
  • Beacon Pointe Advisors first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Beacon Pointe Advisors's Gossamer Bio position peaked at $34.1K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.